Suven Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Suven Pharmaceuticals Limited has acquired 51% of the share Capital on a fully diluted basis (i.e., 67.5% of the present equity share capital) of Sapala Organics Private Limited